Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
SPGI SP Global posts small Q4 2025 EPS miss shares dip 051 percent amid muted investor sentiment KDK Kodiak AI earnings shatter estimates with 150 EPS surprise shares rise 26 on momentum Does Varonis Systems VRNS stock justify its valuation Q4 2025 Better Than Expected Quantumsphere QUMSR Stock Cash Secured Put Overhead Buying 20260422 CanopyGrowth CGC Stock Key Growth Drivers 482 20260420 What First FCF is doing to expand margins Q1 2026 Earnings Underperform Why WEBTOON WBTN deserves more attention from serious investors Trend Strengthens 20260508 DexCom Inc DXCM Q1 2026 Earnings Beat Driven by CGM Demand Margin Expansion and Reimbursement Wins What Rani RANI is doing that smarter investors notice Rani posts narrow EPS miss no Q4 revenue data available Cresud CRESY Earnings Outlook Key Metrics for Q1 2026 PAVmed PAVM Q1 2026 Results Fall Short EPS 442 Revenue NA Cisco Leads Market Rally as Dow Jones Approaches 50000 Milestone LSI Industries LYTS Crushes Q1 2026 Estimates EPS 029 Tops Views Rand RAND Earnings Outlook Key Metrics for Q1 2026 Loomis Sayles Global Growth Fund Maintains Shopify SHOP Position Looking Beyond AI Hype RussianBorn Entrepreneur Mikhail Kokorichs Destinus Challenges European Defence Incumbents with Cheaper Missile Systems Global GIC Jumps 258 on Strong Momentum 20260520 APO Q1 2026 Earnings EPS Slightly Misses Estimate Stock Holds Steady ZenaTech Inc ZENA Q4 2025 Earnings Deep Loss Misses Estimates Despite Share Rally LMT Q1 2026 Earnings Earnings Miss Stock Rises Amid Defense Sector Optimism zSpace Q1 2026 Earnings EPS Misses Estimates by Wide Margin as Revenue Remains Absent Sensei Biotherapeutics Inc SNSE Q1 2026 Earnings Deep EPS Miss Reflects Heavy RD Investment and PreRevenue Status Enovix ENVX Surges Over 6 as Bulls Test Key Resistance at 701 Clipper Realty Inc CLPR Tests Support as Selling Pressure Mounts DiaMedica Therapeutics DMAC Gains 243 as Buyers Defend Key Support A10 Networks ATEN Surges 395 Breaking Above Key Resistance Levels